Home Info-Graphs Private Equity Investments In European Healthcare Tumble H2’22

Private Equity Investments In European Healthcare Tumble H2’22

Advertisement Disclosure: When you purchase through our sponsored links, we may earn a commission from our partners. By using this website you agree to our T&Cs.

Global private equity investment in the European healthcare industry fell by more than a quarter in 2022, with the second half of the year seeing a particularly sluggish performance, according to S&P Global Market Intelligence analysis.

The aggregate transaction value for private equity investments in the space came to $18.88 billion across 813 deals in 2022, compared to $25.79 billion from 983 deals a year earlier, according to S&P Global Market Intelligence data.

Q4 2022 hedge fund letters, conferences and more

 

Key Highlights

  • Deal volume for all of 2022 ended up peaking in the first quarter, with 234 transactions bringing in $7.50 billion. In the final three months of the year, investments were down by more than half at $3.28 billion.
  • Healthcare services received the greatest investment, with private equity pouring in $7.01 billion, followed by pharmaceuticals at $3.97 billion and biotechnology at $2.93 billion. The three subsectors accounted for more than 70% of the total private equity investments in European healthcare.

Largest Deals

 

European Healthcare

European Healthcare

European Healthcare

European Healthcare

Our Editorial Standards

At ValueWalk, we’re committed to providing accurate, research-backed information. Our editors go above and beyond to ensure our content is trustworthy and transparent.

Anna Peel
Editor

Want Financial Guidance Sent Straight to You?

  • Pop your email in the box, and you'll receive bi-weekly emails from ValueWalk.
  • We never send spam — only the latest financial news and guides to help you take charge of your financial future.